In terms of the study's primary endpoint, using CCTA to guide procedures was noninferior to IVUS. CCTA was also linked to certain advantages over IVUS, including improved cath lab efficiency.
A new-look cerebral embolic protection device for TAVR is safe to use and consistently captures debris. According to late-breaking data presented at TCT 2026, however, the device failed to demonstrate any tangible clinical benefits.
“We expected that the chances of heart disease would gradually rise as people used cannabis more often, but that wasn’t the case," one researcher said. "Both low-use and heavy-use groups had higher odds of developing heart disease."
Researchers reviewed an FDA safety database, finding that these products were commonly involved in reports related to cardiac arrest, heart attacks, ventricular arrhythmias, heart palpitations, chest pain and fainting.
A lead-free, ceiling-mounted shielding system could significantly reduce occupational radiation exposure among physicians performing fluoroscopy-guided procedures, according to a study presented at TCT 2026.
Men are much more likely to have degenerative mitral valve disease than men, according to a new global analysis presented at TCT 2026 in San Diego. However, women are more likely to die from it.
Traditionally, the interventional cardiologist first visualizes the coronary anatomy in detail when contrast is injected in the catheterization laboratory. For many patients, however, that anatomy has already been captured, often in considerable detail, by coronary CT angiography (CCTA) performed earlier in the clinical pathway. This article considers how this dataset can be used to plan the procedure, an approach referred to as CT-guided PCI.
